Home>>Analytical Standards>>Anthranilic Acid

Anthranilic Acid (Synonyms: NSC 144, NSC 40929)

Catalog No.GC41593

Anthranilic Acid is a potential precursor in the synthesis of quinazolinones, including methaqualone.[1]

Products are for research use only. Not for human use. We do not sell to patients.

Anthranilic Acid Chemical Structure

Cas No.: 118-92-3

Size Price Stock Qty
10mg
$33.00
In stock
50mg
$73.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Video Related Products

Anthranilic Acid is a potential precursor in the synthesis of quinazolinones, including methaqualone.[1] For this reason, anthranilic acid, its esters, and its salts are categorized as List I chemicals with the Drug Enforcement Administration in the United States. Anthranilic acid is also a natural antimicrobial metabolite produced by a number of bacterial strains.[2] This product is intended for research and forensic applications.

Reference:
[1]. Soliman, F.S., Shafik, R.M., and Elnenaey, E.A. Synthesis of methaqualone and its diphasic titration in pure and tablet forms. Journal of Pharmaceutical Sciences 67(3), 411-413 (1978).
[2]. Hund, H.K., de Beyer, A., and Lingens, F. Microbial metabolism of quinoline and related compounds. VI. Degradation of quinaldine by Arthrobacter sp. Biological Chemistry of Hoppe-Seyler 371(10), 1005-1008 (1990).

Reviews

Review for Anthranilic Acid

Average Rating: 5 ★★★★★ (Based on Reviews and 9 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Anthranilic Acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.